Radiation InjuriesRadiation DosageAntineoplastic Combined Chemotherapy ProtocolsRadiation, IonizingAntineoplastic AgentsDose-Response Relationship, RadiationCombined Modality TherapyRadiotherapyRadiation ToleranceRadiotherapy DosageChemotherapy, AdjuvantRadiationRadiation OncologyRadiation ProtectionRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedRadiation MonitoringCisplatinTreatment OutcomeRadiotherapy, AdjuvantDoxorubicinDose FractionationNeoplasmsRadiation PneumonitisRadiotherapy Planning, Computer-AssistedCell Line, TumorBrachytherapyBreast NeoplasmsNeoplasm StagingNeoplasm Recurrence, LocalRadiation-Sensitizing AgentsRadiometryNeoplasms, Radiation-InducedDisease-Free SurvivalBrain NeoplasmsRadiation Injuries, ExperimentalSurvival AnalysisDrug Screening Assays, AntitumorRadiosurgeryEtoposideGamma RaysCyclophosphamideSurvival RateCranial IrradiationDrug Resistance, NeoplasmLung NeoplasmsCosmic RadiationPrognosisHead and Neck NeoplasmsApoptosisTime FactorsPaclitaxelRadiotherapy, Computer-AssistedAntineoplastic Agents, PhytogenicNeoadjuvant TherapyAdenocarcinomaCell SurvivalParticle AcceleratorsFollow-Up StudiesRadiotherapy, Image-GuidedCarcinoma, Squamous CellRadiation-Protective AgentsRadiotherapy, High-EnergyRadiodermatitisAntibiotics, AntineoplasticBackground RadiationChemoradiotherapyDrug Administration ScheduleVinblastineBleomycinCarboplatinDNA DamageProstatic NeoplasmsAntineoplastic Agents, AlkylatingTomography, X-Ray ComputedAntimetabolites, AntineoplasticOrgans at RiskUltraviolet RaysCarcinoma, Non-Small-Cell LungDacarbazineMethotrexateXenograft Model Antitumor AssaysMice, NudeCobalt RadioisotopesTumor Cells, CulturedTumor BurdenHodgkin DiseaseRadiation EffectsDose-Response Relationship, DrugClinical Trials as TopicRetrospective StudiesCamptothecinOrganoplatinum CompoundsDrug Delivery SystemsNeoplasm MetastasisMastectomy, SegmentalDeoxycytidineActuarial AnalysisRadiobiologyGlioblastoma